RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/10773581http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/10773581http://www.w3.org/2000/01/rdf-schema#comment"To investigate potential effects of endogenous parathyroid hormone-related peptide (PTHrP) on osteoblast function, ROS 17/2.8 cells were transfected with full-length PTHrP cDNA in a sense or antisense orientation to alter PTHrP production. Compared with vector-transfected control cells, PTHrP-overproducing (sense-transfected) cells showed increased DNA synthesis ([(3)H]-thymidine incorporation) and increased growth (cell number). The extent of apoptosis was compared for the different clones using the terminal deoxynucleotide-mediated dUTP nick-end-labeling assay (TUNEL) and Hoechst staining. No differences in percentages of apoptotic cells were found under basal culture conditions or after 3 days of serum deprivation, which, itself, markedly increased numbers of apoptotic cells. The effect of PTHrP on osteoblast differentiation was assessed by examining two protein markers of differentiation, alkaline phosphatase, and bone morphogenetic protein (BMP)-2. Alkaline phosphatase activity was decreased in sense-transfected cells and increased in antisense-transfected cells, compared with cells transfected with empty vector. PTHrP-overproducing cells also showed decreased numbers of BMP-2-positive cells, whereas antisense-transfected cells showed no difference compared with vector control. The results indicate that: (a) endogenously produced PTHrP can increase growth of these osteoblastic cells by stimulating proliferation while not affecting apoptosis; and (b) the increased cell proliferation produced by PTHrP was accompanied by a reduction in activity or amount of two proteins normally expressed by differentiated osteoblasts."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.org/dc/terms/identifier"doi:10.1016/s8756-3282(00)00264-7"xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Li H."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Wang C."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Du P."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Ye Y."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Cooper C.W."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Seitz P.K."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Bi L.G."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/author"Simmons D.J."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/date"2000"xsd:gYear
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/name"Bone"xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/pages"429-436"xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/title"Endogenous parathyroid hormone-related peptide enhances proliferation and inhibits differentiation in the osteoblast-like cell line ROS 17/2.8."xsd:string
http://purl.uniprot.org/citations/10773581http://purl.uniprot.org/core/volume"26"xsd:string
http://purl.uniprot.org/citations/10773581http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/10773581
http://purl.uniprot.org/citations/10773581http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/10773581
http://purl.uniprot.org/uniprot/P12272#attribution-3056D38237CEFD9FB45FC8003ABFE2D4http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/10773581